RxDoctor Payments Data

Kamran Karimi, MD

Vascular Surgery · Edina, MNNPI 1215947288

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 30.8% of the total. 2025 is the largest year on record at $4,044, 3.2 times the $1,246 reported in 2019.

$14,533in general payments, 2019–2025

Across 112 payments — averaging $129.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Boston Scientific$2K
  • Terumo Medical Corporation$2K
  • Gyrus ACMI, Inc.$2K
  • Silk Road Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$761
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$3,63825%
  • Speaking & faculty fees$1711%
  • Travel & lodging$2,65518%
  • Food & beverage$8,05055%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,533 in reported general payments places this provider in the 85th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$85,502
Medicare patients
246
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate44$602
Atorvastatin Calcium17$226
Oxycodone Hcl13$52
Tramadol Hcl14$26
Lorazepam11$13
Clonidine Hcl13$12

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →